Clinical Trial Update: A Study of FMT in Patients With AML Allo HSCT in Recipients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fecal microbiota transplantation in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Acute Myeloid Leukemia, Allogeneic Hematopoietic Cell Transplantation | Phase 2 | Status: COMPLETED | Results posted: 2024-05-16